1. Introduction
===============

Despite improvements in the diagnosis and treatment of infective endocarditis (IE), emboli are still a relatively common complication (22%--50%), especially in patients with left-side infective endocarditis (LS-IE).^\[[@R1]--[@R7]\]^ Most of these emboli are produced in the first 2 to 4 weeks of antibiotic treatment and for the most part are in the central nervous system (CNS).^\[[@R7]--[@R9]\]^ They have also been found in the abdomen, vessels, and musculoskeletal system.^\[[@R7],[@R10]\]^ Two studies have confirmed that the rate of embolic events decreases dramatically during and after the first 2 to 3 weeks after successful antibiotic therapy.^\[[@R8],[@R11]\]^ The size of the vegetation (\>1 cm), its mobility, the affects valve (mitral valve: anterior leaflet), and the causative agent (*Staphylococcus aureus*, *Candida*, and *Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella -*HACEK- microorganisms*)* are factors that seem to predispose their occurrence.^\[[@R7],[@R8],[@R12]--[@R14]\]^ In the abdomen, the most frequent LS-IE complication sites are the spleen and kidneys, where vascular occlusion created by the emboli will produce an infarction that sometimes can evolve into an abscess formation.^\[[@R15],[@R16]\]^ Ultrasound (US), computed tomography (CT), and more recently magnetic resonance imaging (MRI) are the most commonly used techniques when abdominal involvement is suspected in patients with LS-IE.^\[[@R16],[@R17]\]^ However, despite the relative frequency of these complications, few studies^\[[@R5],[@R18]\]^ have reported if patients with emboli seen on abdominal images have different clinical and etiological characteristics than those without them. Although it could be hypothesized that the involvement of these abdominal organs could cause a poorer prognosis, the influence of the awareness of the presence of these lesions in the treatment and prognosis of LS-IE is unknown.

The aim of this study was to study whether patients with LS-IE who presented embolic complications on abdominal CT had different epidemiological and clinical characteristics, treatment or outcome than those who did not, in order to know the usefulness of performing routine abdominal CT.

2. Methods
==========

From May 2008 to April 2010, a prospective multicenter cohort study was carried out in 25 Spanish hospitals. These centers are included in the Spanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES).^\[[@R19]\]^ Specific data on demographics, medical history, predisposing factors, microbiology, imaging studies, echocardiography, complications, antibiotic therapy, surgery, and outcomes were obtained for each patient. Cases of definite and possible LS-IE were defined according to the modified Duke criteria.^\[[@R20]\]^

Of the 25 centers that collected the data, 6 participated in this study. A total of 206 patients had a CT performed and 147 with the abdomen included. Almost one-third (43) of these abdominal CTs were performed as part of a study to identify the frequency of abdominal affectation in IE patients, and the rest because of patient symptoms. Patients with spleen, renal or liver (SRL) infarcts, or abscesses on abdominal CT were compared to those with normal CT scans. Only the first abdominal CT was considered in the analysis. The definitions were described previously.^\[[@R19]\]^

Abdominal CT studies were carried out via 2 to 64 multiple detector computed tomography (MDCT) scans after the administration of an intravenous contrast agent. In the spleen, renal, and liver, infarct was defined as a triangular area of low density that did not show enhancement.^\[[@R16],[@R21]\]^ An abscess was considered if there was gas within the hypodense lesion or a capsule around the hypodense defect on the CT performed after the administration of an intravenous contrast agent.^\[[@R21]\]^

Replacement or repair of the affected valve or correction of anatomical abnormality and/or debridement during the hospitalization for IE was divided in 3 periods: emergency surgery (\<8 days), early surgery (8--21 days), and late surgery (\>22 days).

2.1. Statistical analysis
-------------------------

Patients with LS-IE and SRL infarcts or abscesses on abdominal CT scan were compared to those with normal CT. Quantitative variables were expressed as mean and standard deviation (SD) or as medians with interquartile range (IQR) as appropriate; qualitative variables were expressed as frequency and percentage. Continuous variables were compared using the *t*-test, and categorical variables were compared using the chi-squared test or Fisher\'s exact test when the chi-square test was not appropriate. The Mann--Whitney *U* test was used to compare nonparametric variables. Multivariate analysis was performed using a stepwise logistic regression (with a significance level for removal from the model and for addition to the model of 0.2) and adjusted odds ratios (OR) and their 95% confidence intervals (CI) were calculated to analyze the association between different exposure variables and the presence of SRL lesions on CT or in-hospital mortality. A curve of survival was obtained using the Kaplan--Meier method, calculating survival rates for the time elapsed between discharge and 1-year mortality in patients surviving hospitalization. The heterogeneity of the curves was tested using the log-rank test. Cox regression was applied to estimate survival rate over time as a function of several covariates. Hazard ratios (HR) and their 95% CI were calculated.

A two-tailed *P \< *.05 was considered statistically significant. The data were analyzed using SPSS (version 19) (SPSS Inc., Chicago, IL) statistical software.

2.2. Ethics
-----------

The entire project and the common case report forms were approved by the national and local institutional review boards and ethics committees (E.C. 155 18/07). All patients signed an informed consent according to established standards.

3. Results
==========

Of the 147 patients included in the study, 136 (92.5%) had a CT performed after the administration of an intravenous contrast agent. The median time between hospital admission and abdominal CT was 6 days (IQR 4--14) in the SRL group and 8 days (IQR 4--22) in the patients without SRL. Table [1](#T1){ref-type="table"} shows the demographic characteristics of the entire population, those with SRL emboli and those with normal CT images. As can be seen, 50 (34%) of 147 patients had SRL emboli: 44 splenic infarcts, 15 kidney infarcts, 1 liver infarct, and 2 liver abscesses. Ten patients had more than 1 organ involved, mainly spleen and renal infarcts. We did not find differences in the incidence of SRL infarcts of patients with abdominal CT scan performed routinely (n = 43; 27.90% of patients had SRL infarcts) or because a clinical indication (n = 104; 36.53% of patients had SRL lesions) (*P = *.475). There were 42 (84%) men with a median age of 63 years (IQR 50.7--76) in the group of patients with SRL emboli and 62 (63.9%) men with a median age of 68 years (IQR 61--76.5) in the group without emboli on CT images (*P = *.013 and *P = *.064, respectively).
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Epidemiological and clinical characteristics of 147 patients with left-side infective endocarditis and abdominal CT^∗^ scan.
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Natural valve affectation (84.0% vs 69.1%, *P = *.050) and both mitral and aortic valve involvement were higher in the patients with SRL emboli, 12 (24.5%) vs 10 (10.4%); *P = *.042. The underlying conditions and site of acquisition were similar in patients with and without SRL emboli except for the presence of liver disease (*P = *.001) and number of human immunodeficiency virus (HIV) (*P = *.039) or intravenous drug users (IVDU) (*P = *.038) patients, which were more frequent in the patients with SRL emboli on CT.

Clinical manifestations were also similar, with fever being the most frequent finding in both groups. The only differences were nonabdominal emboli (*P = *.001) as well as splenomegaly (*P = *.001), which were significantly more frequent in the SRL group. In the stepwise logistic regression analysis, male gender (OR 3.6, 95% CI 1.4--9.1; *P = *.008), presence of liver disease (OR 8.3, 95% CI 2.1--31.8; *P = *.002), and nonabdominal emboli (OR 5.2, 95% CI 2.3--11.7; *P = *.0001) were the only predictors of emboli on the CT scan.

Regarding the etiology (Table [2](#T2){ref-type="table"}), no statistically differences were seen in the microorganisms isolated in patients with or without abdominal emboli (*P = *.56). *Streptococci*, followed by *S aureus* and coagulase-negative *staphylococci* were the most frequently isolated microorganisms in the group with SRL emboli. In 10% of patients, the etiology of LS-IE was unknown. In the 2 patients with liver abscesses, the isolated microorganisms were *S aureus* and *Streptococcus oralis.*

###### 

Etiology of 147 patients with left-side infective endocarditis and abdominal CT scan.
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Table [3](#T3){ref-type="table"} shows the main echocardiographic findings. 119 out 147 patients (80.9%) had a transesophageal echocardiography (TEE), 80% in the SRL group and 81.4% in normal CT scan group. Vegetation in the mitral and aortic valves was similar in both groups. However, the presence of vegetation in the mitral and aortic valves predominated in the group of patients with SRL (22% vs 8.2%) (*P = *.051). No differences were seen between the 2 groups regarding intracardiac complications, valve perforation, pseudoaneurysm, abscess, or fistula. Patients with SRL emboli on CT scan had more and larger (86.0%) vegetation than those with normal CT (presence of vegetation longer than 15 mm in 33.3% vs 15.3%; *P = *.049)
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Echocardiographic findings of 147 patients with left-side infective endocarditis and abdominal CT scans.

![](medi-97-e11952-g003)

Treatment details and outcomes are shown in Table [4](#T4){ref-type="table"}. No statistically significant differences were seen between both groups regarding the type and duration of antibiotics and timing or reasons for surgery. Patients with and without SRL emboli on abdominal CT had similar hospitalization (median = 47 days, IQR: 29--59.5 vs 48 days, IQR: 29.7--57.5\]) and median hospital stay (48 days, IQR 29.7--57.5 vs 47 days, IQR 29--59.5 *P = *.98). There were no statistically significant differences in global hospital deaths or 1-year mortality between both groups (Table [4](#T4){ref-type="table"}). A total of 34 patients (23.1%) died during hospitalization: 13 (26%) had abdominal emboli vs 21 (21.6%) with normal CT (*P = *.55). During the 1-year follow-up, there were 13 deaths: 6 (16.2%) patients with abdominal emboli vs 7 (9.2%) without them (*P = *.35) (Table [4](#T4){ref-type="table"}). We also did not find statistically significant differences in the incidence of global hospital deaths: 8 out of 43 (18.6%) patients died when routine abdominal CT scan was performed and 26 out of 104 (25.0%) when because of clinical indication (*P = *.40). Similarly, no statistically significant differences were observed in 1-year mortality between the 2 groups: 3 deaths (8.6%; n = 35 alive at discharge) when the CT was routinely indicated compared with 10 deaths (12.8%; n = 78 alive at discharge) among those performed because a clinical indication (*P = *.51).
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Antibiotics, surgery treatments, and outcomes in 147 patients with left-side infective endocarditis and abdominal CT scans.
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The Kaplan--Meier survival curve in the patients with or without SRL lesions on abdominal CT estimates of 1-year overall survival without statistically significant differences between patients with and without abdominal emboli on CT (Fig. [1](#F1){ref-type="fig"}): mean survival time of 323.4 days vs 342.4 days (*P = *.26). Similarly, in Cox regression analysis, patients with SRL lesions on abdominal CT did not have a significantly higher death hazard than patients without them (HR adjusted by sex 1.85, 95% CI 0.61--5.61, *P = *.28).

![Kaplan--Meier survival curve of patients with left-left side infective endocarditis with and without spleen, liver and renal (SRL) lesions on abdominal computed tomography (CT) scans.](medi-97-e11952-g005){#F1}

The stepwise regression model selected sex as the unique significant predictor of in-hospital mortality (OR 3.03 95% CI 1.23--7.46, *P = *.016). Other factors selected in the model were the presence of vegetation (OR 3.28, 95% CI 0.89--12.09, *P = *.074) and SLE emboli on CT (OR = 1.92, 95% CI 0.78--4.70, *P = *.15), although there were no statistically significant differences.

4. Discussion
=============

Abdominal CT, US, and MRI have been used to explore abdominal complications in patients with SRL. However, in clinical practice, US and CT are the most frequently used, especially CT, which is considered superior to US for screening due to its ability to detect changes even in patients with normal ultrasound.^\[[@R15],[@R18]\]^ Almost all CT explorations in this study were performed after the administration of an intravenous contrast agent when infarcts and abscesses were better seen and in the first 2 weeks after hospital admission when the risk of embolic events was higher.^\[[@R7],[@R8]\]^

The proportion of patients with SRL (34%) in our study is similar to other series of the postantibiotic era,^\[[@R22]\]^ although relatively high compared to recent series such as Luaces et al,^\[[@R18]\]^ Millaire et al,^\[[@R5]\]^ or Aalaei-Andabili et al,^\[[@R23]\]^ where SRL was around 10%. It is possible that the method of selection (with a large group of patients who underwent a CT scan systematically) and the time when the CT was performed result in these differences.^\[[@R7],[@R24]\]^

The vascular obstruction produced by an emboli in a patient with LS-IE can result in a splenic, renal, or hepatic abscess; however, most lesions correspond to infarcts and only a small proportion (\<4.8%) to abscesses.^\[[@R16],[@R17],[@R24],[@R25]\]^ Most are located in the spleen and kidney and only a small proportion in the liver, due to the double arterial and portal circulation.^\[[@R12]\]^ In agreement with these data, practically all of the lesions detected in our study corresponded to infarcts. The majority was in the spleen and kidney, and only 2 patients had liver abscesses that resolved adequately with medical treatment. None of our patients underwent surgical treatment because of splenic, renal, or hepatic involvement during the 1-year of follow up.

Left upper pain or flank pain and splenomegaly or hematuria are the most frequent symptoms and signs in patients with SRL infarcts. However, many of these patients are asymptomatic, and an infarct is an incidental finding on CT, MRI, or US.^\[[@R24]\]^ Our patients, independent of the presence or absence of SRL emboli had similar characteristics in terms of the type of site of acquisition, clinical background, and causal microorganism. The only significant differences we found compared to other studies^\[[@R12],[@R18],[@R24]\]^ were the predominance of men, the mitral-aortic valve involvement,^\[[@R24]\]^ the presence of liver disease,^\[[@R26]\]^ splenomegaly,^\[[@R18]\]^ the number of HIV and IVDU patients,^\[[@R12]\]^ and the number of nonabdominal emboli, which were more frequently found in the patients with SRL lesions. In our study as well as in Luaces et al.^\[[@R18]\]^ study, patients with SRL infarcts were younger than those without abdominal affectation. Our study also shows a trend toward a lower proportion of embolic events in patients with endocarditis in prosthetic valves compared to native valves. Possibly, as Durante Mangoni et al.^\[[@R6]\]^ pointed out, smaller vegetation size, treatment, or age are important factors.

Most embolic complications have been associated with *S aureus*, *Candida*, and HACEK microorganisms^\[[@R7]\]^ infections. In our case, however, although overall *Staphylococci* were the most frequent bacteria causing LS-IE (66.6%), *Streptococcus* species were the most prevalent microorganisms (40%) among patients with SRL embolic events. Geographical reasons and selection bias may explain this finding.^\[[@R1],[@R3],[@R27]\]^ Mitral vegetation, especially in the anterior valve, has been associated with an increased number of embolic events.^\[[@R28],[@R29]\]^ In our series, mitro-aortic valve vegetation had more SRL lesions. It seems reasonable to consider as did Ting et al^\[[@R24]\]^ that patients with concurrent aortic and mitral valve endocarditis, which may reflect a more virulent infection, appeared to be at a higher risk for embolization. In addition to the valve affected, vegetation length appears to be a strong predictor of embolic events.^\[[@R12]\]^ Our data support this finding since patients with vegetation longer than 15 mm had more abdominal embolisms.

We did not find a change in the therapeutic approach (medical or surgical) or in the time of surgical treatment between the groups with or without SRL emboli. This is likely due to the fact that most the SRL lesions on abdominal CT scan were infarcts. However, it is important to keep in mind and consider in patients with LS-IE and persistent fever, signs of sepsis or bacteremia, and appropriate antibiotic treatment, the use of an abdominal imaging study seeking SRL abscess that could require specific surgery or percutaneous drainage.^\[[@R30]\]^ Although cases have been described with splenectomy performed during or after cardiac surgery,^\[[@R23],[@R30]--[@R32]\]^ this approach is generally realized previous to cardiac surgery.^\[[@R7],[@R33]\]^

In-hospital and 1-year mortality were similar between patients with or without SRL emboli. Attributable mortality was higher in patients with abdominal involvement but without significant differences. Findings such as those of Lung et al^\[[@R17]\]^ and Luaces et al,^\[[@R18]\]^ in which the presence of abdominal affection in the form of SRL infarcts has little repercussion on the therapeutic treatment, surgery is necessary or death could result.

Several study limitations should be taken into consideration when extrapolating our results. First, this was not a clinical trial, so the results should be interpreted with caution. Second, this study was performed in most of the patients in whom the multidisciplinary team of experts asked for abdominal CTs due to clinical suspicion of abdominal emboli. This could have led to selection bias because our series may not represent the situation of all patients with LS-IE, but those who may have a worse outcome. Another possible bias could result from the fact that abdominal CT was interpreted in each center, and inter-individual variability was not evaluated. In addition, although it is a multicenter survey with a large number of patients recruited, the number of deaths could be considered relatively small, and this may lack the statistical power to detect some associations, mainly those with little influence. However, there are no other studies that include a concomitant endocarditis and analyze the influence of emboli complications on abdominal CT in patients with LS-IE with this long-term follow-up.

In summary, despite the limitations, our results showed that males with LS-IE liver disease and nonabdominal emboli had more risk of abdominal emboli found on CT scan. The presence of SRL infarcts on abdominal CT scan performed on patients with LS-IE within 2 weeks after hospital admission seems to have poor practical implications. We did not find differences in the incidence of SRL infarcts when CT scan was performed routinely or with clinical indication. New studies should be done to confirm these preliminary results.
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